Published in J Clin Endocrinol Metab on June 01, 1998
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest (2007) 1.22
Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia. J Clin Invest (1999) 1.10
A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26. Am J Hum Genet (2000) 0.90
Variable expressivity and co-occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy. Mol Genet Genomic Med (2016) 0.77
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature (1994) 4.28
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med (2001) 4.17
Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J Biol Chem (1981) 3.54
Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet (1992) 3.33
Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem (1982) 3.22
Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies. J Cell Biol (1982) 2.84
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med (2001) 2.56
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Advances in the gas chromatographic analysis of amino acid phenyl- and methylthiohydantoins. Anal Biochem (1972) 2.56
Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J Med Genet (2001) 2.55
Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc Natl Acad Sci U S A (1985) 2.53
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet (2001) 2.39
Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology (1997) 2.39
Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem (2001) 2.26
Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir. Aliment Pharmacol Ther (2013) 2.21
Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia. J Biol Chem (1982) 2.13
Implementation of the quality management system improves postoperative pain treatment: a prospective pre-/post-interventional questionnaire study. Br J Anaesth (2012) 2.09
Bovine parathyroid hormone: amino acid sequence. Proc Natl Acad Sci U S A (1970) 2.08
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy (2013) 2.08
A sonographically guided technique for central venous access. AJR Am J Roentgenol (1997) 2.05
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet (1994) 2.05
Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) Circulation (1995) 2.01
[Prospective Epidemiologic Study of Epigastric Discomfort (PRESTO). Ground work and preliminary results]. Dtsch Med Wochenschr (1999) 2.01
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest (1986) 1.98
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97
Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut (1999) 1.97
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun (2001) 1.91
Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol (2000) 1.90
Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol (1998) 1.89
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat (2008) 1.85
Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol (1997) 1.83
Association between fulminant hepatic failure and a strain of GBV virus C. Lancet (1996) 1.82
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun (1978) 1.75
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics (1990) 1.74
Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut (2002) 1.74
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy (2006) 1.70
Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med (1994) 1.70
Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. Proc Natl Acad Sci U S A (1972) 1.68
Differential absorption of amoxicillin from the human small and large intestine. Clin Pharmacol Ther (1994) 1.68
Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet (1999) 1.66
The plasma lipoproteins. Adv Protein Chem (1977) 1.65
CFTR and its key role in in vivo resting and luminal acid-induced duodenal HCO3- secretion. Acta Physiol (Oxf) (2008) 1.65
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J (2003) 1.64
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis (1989) 1.64
CREB controls LAP/C/EBP beta transcription. Mol Cell Biol (1997) 1.62
Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res (2001) 1.62
Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol (1997) 1.61
ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest (2001) 1.61
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol (2004) 1.60
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis (1982) 1.57
Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany. Microb Drug Resist (2000) 1.54
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology (1996) 1.53
The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis (2008) 1.52
Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res (2001) 1.51
Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay. J Clin Virol (2007) 1.51
Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry (1990) 1.51
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer (2005) 1.51
Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry (1975) 1.50
Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med (1993) 1.50
Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol (1997) 1.49
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med (1997) 1.48
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun (1980) 1.46
Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. J Clin Invest (1986) 1.46
A mass in the eye. Lancet (2002) 1.46
Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem (1998) 1.45
Structural organization of the hepatitis B virus minichromosome. J Mol Biol (2001) 1.45
Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy (1996) 1.44
Effects of cyclosporine on human dendritic cell subsets. Transplant Proc (2005) 1.43
Multidiscipline treatment of chronic pulmonary insufficiency. 1. Psychologic aspects of rehabilitation. Psychosom Med (1973) 1.43
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A (1999) 1.42
Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence. Proc Natl Acad Sci U S A (1986) 1.42
A cystic fibrosis patient homozygous for the nonsense mutation R553X. J Med Genet (1991) 1.41
Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver. J Biol Chem (1981) 1.41
Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med (1980) 1.41
[Diagnosis of autoimmune hepatitis]. Med Klin (Munich) (1999) 1.40
High-frequency jet ventilation during oleic-acid induced pulmonary oedema. Intensive Care Med (1989) 1.39
High frequency jet ventilation in experimental pulmonary emphysema. Intensive Care Med (1991) 1.39
Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology (2001) 1.38
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet (1997) 1.38
Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet (2000) 1.37
NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med (1983) 1.36